Publications by authors named "Austin P Huffman"

Claim this Profile
V
Vitamin D deficiency after allogeneic hematopoietic cell transplantation promotes T-cell activation and is inversely associated with an EZH2-ID3 signature.
Rodney Macedo, Chloé Pasin, Alex Ganetsky, David Harle, Ximi K Wang, Austin P Huffman

Transplant Cell Ther· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Katelyn T Byrne, Courtney B Betts, Rosemarie Mick, Shamilene Sivagnanam, David L Bajor, Austin P Huffman

Clin Cancer Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis.
Jeffrey H Lin, Austin P Huffman, Max M Wattenberg, David M Walter, Erica L Carpenter

J Exp Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CCL5 mediates CD40-driven CD4+ T cell tumor infiltration and immunity.
Austin P Huffman, Jeffrey H Lin, Samuel I Kim, Katelyn T Byrne, Robert H Vonderheide

JCI Insight· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.
Austin P Huffman, Lee P Richman, Lisa Crisalli, Alex Ganetsky, David L Porter

Biol Blood Marrow Transplant· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxis.
Ryan H Moy, Austin P Huffman, Lee P Richman, Lisa Crisalli, Ximi K Wang

Blood· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning.
Ran Reshef, Austin P Huffman, Amy Gao, Marlise R Luskin, Noelle V Frey

J Clin Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis